---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-033877"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T22:51:55.201231+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BIO-key receives Nasdaq extension to May 2026 to regain $1 bid price compliance

## Summary
- Nasdaq granted BIO-key an additional 180-day period, until May 4, 2026, to meet the $1.00 minimum bid price rule.
- The extension follows a prior notice from May 9, 2025, and is contingent on meeting all other listing requirements.
- The company intends to effect a reverse stock split if necessary to cure the bid price deficiency.
- Failure to comply by May 4, 2026, will result in Nasdaq delisting; company may appeal.

## SEC filing metadata
- accession: 0001437749-25-033877
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774925033877/0001437749-25-033877-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774925033877/bkyi20251107_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-033877
- JSON: https://secwatch.observer/filing/0001437749-25-033877.json
- Plain text: https://secwatch.observer/filing/0001437749-25-033877.txt

## Source-grounded claims
- claim_id: 2dc8d9f356ff3c7fd6b3ecb79b9f3dd046d365f6
  claim: BIO KEY INTERNATIONAL INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: November 6, 2025, the Company received a letter from Nasdaq (the “ Letter ”) stating that although the Company had not regained compliance with the Bid Price Rule, Nasdaq determined that the Company is eligible for an additional 180-day period, or until May 4, 2026, to regain compliance with the Bid Price Rule. In the Letter, Nasdaq stated that its determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the minimu
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774925033877/0001437749-25-033877-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.